Zobrazeno 1 - 10
of 34
pro vyhledávání: '"U. Bressel"'
Publikováno v:
British Journal of Clinical Pharmacology. 51:609-614
Aims Tamsulosin is an α1-adrenoceptor antagonist for the treatment of symptomatic benign prostatic hyperplasia with a tolerability similar to that of placebo in short-term, placebo-controlled studies with limited patient numbers. The present study w
Publikováno v:
Physical Review Letters. 108
Advanced techniques for manipulation of internal states, standard in atomic physics, are demonstrated for a charged molecular species for the first time. We address individual hyperfine states of rovibrational levels of a diatomic ion by optical exci
Autor:
Sergey Vasilyev, M. Hansen, Bernhard Roth, Alexander Nevsky, U. Bressel, I. Ernsting, T. Schneider, Stephan Schiller
Publikováno v:
CLEO/Europe - EQEC 2009 - European Conference on Lasers and Electro-Optics and the European Quantum Electronics Conference.
One important prerequisite for high-precision spectroscopic measurements on cold molecules is the ability to control the translational as well as internal degrees of freedom of the molecules. For neutral molecules ultracold translational temperatures
Autor:
A. Yu. Nevsky, U. Bressel, I. Ernsting, Ch. Eisele, M. Okhapkin, S. Schiller, A. Gubenko, D. Livshits, S. Mikhrin, I. Krestnikov, A. Kovsh
We demonstrate a diode laser system which is suitable for high-resolution spectroscopy in the 1200 nm and yellow spectral ranges. It is based on a two-facet quantum dot chip in a Littrow-type external cavity configuration. The laser is tunable in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67a69cf935d248bd7b3801bf4cc85a06
Publikováno v:
Prostate cancer and prostatic diseases. 1(6)
We have compared the results of treatment with tamsulosin (0.4 mg once daily) in subgroups of patients with lower urinary tract symptoms suggestive of benign prostatic obstruction, based on two large-scale, open-label, observational studies. Improvem
Autor:
Helmut Schumacher, Ludwig Mehlburger, M. C. Michel, R. F. Schäfers, H. U. Bressel, Mark Goepel
Publikováno v:
Der Urologe B. 38:553-554
Die α1-Blocker haben sich als medikamentose BPH-Therapie etabliert. Vier Praparate sind fur diese Therapieindikation in Deutschland zugelassen: Alfuzosin, Doxazosin, Terazosin und Tamsulosin, wobei Doxazosin und Terazosin auch fur die Behandlung der
Publikováno v:
Chemischer Informationsdienst. Organische Chemie. 2
Publikováno v:
Chemischer Informationsdienst. Organische Chemie. 2
Autor:
U. Bressel, R. W. Hoffmann
Publikováno v:
Angewandte Chemie International Edition in English. 6:808-809
Autor:
U. Bressel, R. W. Hoffmann
Publikováno v:
Angewandte Chemie. 79:823-824